First Time Loading...

Iterum Therapeutics PLC
NASDAQ:ITRM

Watchlist Manager
Iterum Therapeutics PLC Logo
Iterum Therapeutics PLC
NASDAQ:ITRM
Watchlist
Price: 1.67 USD 6.37% Market Closed
Updated: Apr 27, 2024

Iterum Therapeutics PLC
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Iterum Therapeutics PLC
Operating Income Peer Comparison

Comparables:
PRGO
JAZZ
AVDL
G
GHRS
COPN

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Iterum Therapeutics PLC
NASDAQ:ITRM
Operating Income
-$47.5m
CAGR 3-Years
-14%
CAGR 5-Years
9%
CAGR 10-Years
N/A
Perrigo Company PLC
NYSE:PRGO
Operating Income
$284.1m
CAGR 3-Years
1%
CAGR 5-Years
-10%
CAGR 10-Years
-8%
Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
Operating Income
$659.4m
CAGR 3-Years
9%
CAGR 5-Years
0%
CAGR 10-Years
7%
Avadel Pharmaceuticals PLC
NASDAQ:AVDL
Operating Income
-$137.8m
CAGR 3-Years
-51%
CAGR 5-Years
-30%
CAGR 10-Years
-11%
G
GH Research PLC
NASDAQ:GHRS
Operating Income
-$41.2m
CAGR 3-Years
-351%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Cosmo Pharmaceuticals NV
SIX:COPN
Operating Income
€12.2m
CAGR 3-Years
61%
CAGR 5-Years
N/A
CAGR 10-Years
-1%

See Also

What is Iterum Therapeutics PLC's Operating Income?
Operating Income
-47.5m USD

Based on the financial report for Dec 31, 2023, Iterum Therapeutics PLC's Operating Income amounts to -47.5m USD.

What is Iterum Therapeutics PLC's Operating Income growth rate?
Operating Income CAGR 5Y
9%

Over the last year, the Operating Income growth was -56%. The average annual Operating Income growth rates for Iterum Therapeutics PLC have been -14% over the past three years , 9% over the past five years .